Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issei Imoto

Showing results (121-130 of 241) with videos related to

Pageof 25
Sort By:
Japanese Journal of Clinical Oncology|December 11, 2012
Esophageal squamous cell carcinoma developed 11 years after allogeneic bone marrow transplantation for acute lymphatic leukemiaYutaka Miyawaki, Issei Imoto, Yutaka Tokairin, et al.
Plos One|February 18, 2014
NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progressionMasaya Uno, Yasunori Saitoh, Kanako Mochida, et al.
Cancer Science|October 20, 2005
Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomasKuniyasu Saigusa, Naoya Hashimoto, Hitoshi Tsuda, et al.
Genetic Testing|October 24, 2007
Multiplex PCR/liquid chromatography assay for screening of subtelomeric rearrangementsToru Udaka, Issei Imoto, Yoshinori Aizu, et al.
Cancer Science|April 27, 2007
Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cellsYasuo Shinoda, Ken-Ichi Kozaki, Issei Imoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinomaSatoshi Matsumura, Issei Imoto, Ken-ichi Kozaki, et al.
Cancer Science|February 1, 2022
New insights into the genetic contribution of ALDH2 rs671 in pancreatic carcinogenesis: Evaluation by mediation analysisYuriko N Koyanagi, Isao Oze, Yumiko Kasugai, et al.
Communications Biology|May 12, 2021
JRAB/MICAL-L2 undergoes liquid-liquid phase separation to form tubular recycling endosomesAyuko Sakane, Taka-Aki Yano, Takayuki Uchihashi, et al.
Carcinogenesis|March 5, 2010
Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinomaShigeo Haruki, Issei Imoto, Ken-ichi Kozaki, et al.
Cancer Science|April 27, 2007
BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell lineTsutomu Kawasaki, Sana Yokoi, Hitoshi Tsuda, et al.
Pageof 25

Showing results (121-130 of 241) with videos related to

Sort By:
Pageof 25
Japanese Journal of Clinical Oncology|December 11, 2012
Esophageal squamous cell carcinoma developed 11 years after allogeneic bone marrow transplantation for acute lymphatic leukemiaYutaka Miyawaki, Issei Imoto, Yutaka Tokairin, et al.
Plos One|February 18, 2014
NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progressionMasaya Uno, Yasunori Saitoh, Kanako Mochida, et al.
Cancer Science|October 20, 2005
Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomasKuniyasu Saigusa, Naoya Hashimoto, Hitoshi Tsuda, et al.
Genetic Testing|October 24, 2007
Multiplex PCR/liquid chromatography assay for screening of subtelomeric rearrangementsToru Udaka, Issei Imoto, Yoshinori Aizu, et al.
Cancer Science|April 27, 2007
Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cellsYasuo Shinoda, Ken-Ichi Kozaki, Issei Imoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinomaSatoshi Matsumura, Issei Imoto, Ken-ichi Kozaki, et al.
Cancer Science|February 1, 2022
New insights into the genetic contribution of ALDH2 rs671 in pancreatic carcinogenesis: Evaluation by mediation analysisYuriko N Koyanagi, Isao Oze, Yumiko Kasugai, et al.
Communications Biology|May 12, 2021
JRAB/MICAL-L2 undergoes liquid-liquid phase separation to form tubular recycling endosomesAyuko Sakane, Taka-Aki Yano, Takayuki Uchihashi, et al.
Carcinogenesis|March 5, 2010
Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinomaShigeo Haruki, Issei Imoto, Ken-ichi Kozaki, et al.
Cancer Science|April 27, 2007
BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell lineTsutomu Kawasaki, Sana Yokoi, Hitoshi Tsuda, et al.
Pageof 25